National Drug Abuse Treatment

  PROTOCOL NIDA-CTN-0031-A-3


Organizational and Practitioner Influences on Implementation of STAGE-12

Dennis McCarty, Ph.D.
Co-Lead Investigator
Oregon Health & Science University
3181 Southwest Sam Jackson Park Rd, CB-669
Portland, OR 97239
mccartyd@ohsu.edu

Joseph Guydish, Ph.D.
Co-Lead Investigator

Institute for Health Policy Studies
University of California, San Francisco
3333 California St., Suite 265
San Francisco, CA 94118
joseph.guydish@ucsf.edu

This CTN-funded ancillary study is related to CTN-0031, "Stimulant Abusers Group to Engage in 12-Step (STAGE-12)."

This project, in collaboration with NIDA DESPR, examines the organizational and counselor level factors that influence the eventual implementation of findings from the STAGE-12 clinical trial. Initial data collection at each of the sites took place prior to selection or training of study clinicians. Counselors and supervisors completed six research instruments and one semi-structured interview. This baseline data collection supported the development of an R01 application to conduct secondary analyses and evaluate implementation of the STAGE-12 intervention in the participating treatment centers during the protocol and after protocol completion.

  LATEST PUBLICATIONS AND DATA

Find publications in the Library about Protocol CTN-0031-A-3

NODES & CTPs SEARCH LINK
Oregon/Hawaii (Lead) search www
California/Arizona (Lead) search www
RELATED PROTOCOLS
NIDA-CTN-0031 search www


Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2010 -- http://ctndisseminationlibrary.org/protocols/ctn0031a3.htm
info@ctndisseminationlibrary.org